Peptide Tools to Study SARS-CoV-2
JPT has launched a broad development program to provide access to genome spanning SARS-CoV-2 peptide tools and its different mutation variants for applications such as:- SARS-CoV-2 clinical trial immune monitoring
- SARS-CoV-2 evaluation of cross reactivities
- SARS-CoV-2 blood and sero test development
- SARS-CoV-2 T-and B-cell epitope discovery
We have broadened our portfolio of coronavirus related products beyond SARS-CoV-2, including SARS-CoV, MERS-CoV and common cold viruses CoV 229E, OC43, HKU1 and NL63. Have a look below!
Overview of Spike Glycoprotein Mutations Flyer: Covid-19 Peptide Tools
Find SARS-CoV-2 peptide tools by research area
Cellular Immunity
-> PepMix™ Peptide Pools
- Antigen-specific T-cell stimulation
- Cellular immune monitoring
- Vaccine target discovery
- Blood test development
- Cross reactivity testing (SARS-CoV-2 vs. SARS, MERS, HCoV 229E, OC43…)
- Cell therapy development
- Efficient epitope mapping and identification
- Matrix Pools and individual peptides spanning a whole antigen in one set
- Minimal sample amount required
- Antigen specific T-cell stimulation in T-cell assays (i.e. ELISpot, ICS)
- Immune monitoring
- Proliferation assays
- T-cell expansion
Humoral Immunity
-> PepStar™ Peptide Microarrays
- Humoral immune monitoring
- Antibody epitope discovery
- Cross reactivity testing (SARS-CoV-2 vs. SARS, MERS, HCoV 229E, OC43…)
- Seromarker discovery
PepStar™ Antigen Collection Pan-Coronavirus
for cross reactivity testing with SARS-CoV-2 vs. SARS, MERS, HCoV 229E, OC43…)
PepStar™ Peptide Microarrays
for individual SARS-CoV-2 and SARS-CoV antigens
Tailored PepStar™ Peptide Microarrays
You define content and layout, we provide economic and fast production in our regulated clean-room environment. We also offer our assay and analysis service using your samples with your tailored peptide microarray.
- Thousands of peptides spanning the entire SARS-CoV-2 genome using smallest sample volumes
- Incubation using smallest sample volumes
- Study of antibody cross-reactivities between SARS-CoV-2 and other corona viruses
- Verification of peptide binders with a large numbers of samples
- Transfer of results to ELISA platform for rapid test development
- Peptide ELISA development and service using SARS-CoV-2 peptides or a combination with other corona viruses
- ELISA-based validation service of peptide binders identified by using JPT’s peptide microarray platform
- Collaborative ELISA test development
Clinical Immune Monitoring & Cell Therapy
-> Clinical Grade Peptides & PepMix™ Peptide Pools
- High quality chemically synthesized antigen source for vaccine trial monitoring
- Ancillary reagents for cellular therapy development
- Full analytical coverage, stability testing, batch documentation and more
Proteomics
-> SpikeMix™ SARS-CoV-2
- Identify SARS CoV-2 antigens from biological samples
- Mass spectrometry based assays (MRM)
- Screen 23 proteotypic peptides from SARS-CoV-2
Loading...